Meta-Analysis of the Alzheimer’s Disease Human Brain Transcriptome and Functional Dissection in Mouse Models

Wan, Ying-Wooi, Al-Ouran, Rami, Mangleburg, Carl G., Perumal, Thanneer M., Lee, Tom V., Allison, Katherine, Swarup, Vivek, Funk, Cory C. +56 more·2020·Cell Reports

Cited by (297)

Items 101–200 of 297

  1. Whole-body metabolic modelling reveals microbiome and genomic interactions on reduced urine formate levels in Alzheimer’s disease
    Filippo Martinelli, Almut Heinken, Ann‐Kristin Henning, Maria A. Wörheide, Tim Hensen, Antonio González, Matthias Arnold, Sanjay Asthana, Kathrin Budde, Corinne D. Engelman et al. · 2024 · Scientific Reports
  2. Unified AI framework to uncover deep interrelationships between gene expression and Alzheimer’s disease neuropathologies
    Nicasia Beebe-Wang, Safiye Çelik, Ethan Weinberger, Pascal Sturmfels, Philip L. De Jager, Sara Mostafavi, Su‐In Lee · 2021 · Nature Communications
  3. Computational Interspecies Translation Between Alzheimer’s Disease Mouse Models and Human Subjects Identifies Innate Immune Complement, TYROBP, and TAM Receptor Agonist Signatures, Distinct From Influences of Aging
    Meelim J. Lee, Chuangqi Wang, Molly J. Carroll, Douglas K. Brubaker, Bradley T. Hyman, Douglas A. Lauffenburger · 2021 · Frontiers in Neuroscience
  4. Integration of transcriptome-wide association study with neuronal dysfunction assays provides functional genomics evidence for Parkinson’s disease genes
    Jiayang Li, Bismark Kojo Amoh, Emma McCormick, Akash Tarkunde, Katy Fan Zhu, Alma M. Perez, Megan L. Mair, Justin Moore, Joshua M Shulman, Ismael Al‐Ramahi et al. · 2022 · Human Molecular Genetics
  5. Reduction in GABAB on glia induce Alzheimer’s disease related changes
    Amanda M. Leisgang Osse, Ravi S. Pandey, Ryan A. Wirt, Andrew Adonay Ortiz, Arnold Salazar, Michael J. Kimmich, Erin N. Toledano Strom, Adrian L. Oblak, Bruce T. Lamb, James Michael Hyman et al. · 2023 · Brain Behavior and Immunity
  6. Predictive network analysis identifies JMJD6 and other potential key drivers in Alzheimer’s disease
    Julie P. Merchant, Kuixi Zhu, Marc Henrion, Syed Shujaat Ali Zaidi, Branden Lau, Sara Moein, Melissa L. Alamprese, Richard V. Pearse, David Alan Bennett, Nilüfer Ertekin‐Taner et al. · 2023 · Communications Biology
  7. Dual roles of UPRer and UPRmt in neurodegenerative diseases
    Si Xu, Haihui Liu, Chen Wang, Yu Lin Deng, Bin Xu, Tianyao Yang, Wei Liu · 2023 · Journal of Molecular Medicine
  8. TMEM106B coding variant is protective and deletion detrimental in a mouse model of tauopathy
    George A. Edwards, Caleb A. Wood, Yang He, Quynh Nguyen, Peter J. Kim, Ruben Gomez‐Gutierrez, Kyung-Won Park, Yong Xu, Cody Zurhellen, Ismael Al‐Ramahi et al. · 2024 · Acta Neuropathologica
  9. Dysregulated gene-associated biomarkers for Alzheimer’s disease and aging
    Min Li, Rongxin Geng, Chen Li, Fantao Meng, Hongwei Zhao, Jing Liu, Juanjuan Dai, Xuezhen Wang · 2021 · Translational Neuroscience
  10. Single-cell anatomical analysis of human hippocampus and entorhinal cortex uncovers early-stage molecular pathology in Alzheimer’s disease
    José Dávila-Velderrain, Hansruedi Mathys, Shahin Mohammadi, Brad Ruzicka, Xueqiao Jiang, Ayesha P. Ng, David Alan Bennett, Li‐Huei Tsai, M Kellis · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  11. Recent developments and future directions in meta-analysis of differential gene expression in livestock RNA-Seq
    Brittney N. Keel, Amanda K. Lindholm‐Perry · 2022 · Frontiers in Genetics
  12. Unraveling Psychiatric Disorders through Neural Single-Cell Transcriptomics Approaches
    Samar Nasser Chehimi, Richard C. Crist, Benjamin C. Reiner · 2023 · Genes
  13. Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways
    Ibanez, Kristen R., McFarland, Karen N., Phillips, Jennifer, Allen, Mariet, Lessard, Christian B., Zobel, Lillian, De La Cruz, Elsa Gonzalez, Shah, Shivani, Vo, Quan, Wang, Xue et al. · 2022 · Alzheimer's Research & Therapy
  14. Genetic diversity promotes resilience in a mouse model of Alzheimer's disease
    Neelakshi Soni, Lindsay A. Hohsfield, Kristine M. Tran, Shimako Kawauchi, Amber Walker, Dominic I. Javonillo, Jimmy Phan, Dina P. Matheos, Celia Da Cunha, Asli Uyar et al. · 2024 · Alzheimer s & Dementia
  15. Integration of plasma and CSF metabolomics with CSF proteomic reveals novel associations between lipid mediators and central nervous system vascular and energy metabolism
    Kamil Borkowski, Nicholas T. Seyfried, Matthias Arnold, James J. Lah, Allan I. Levey, Chadwick M. Hales, Eric B. Dammer, Colette Blach, Gregory Louie, Rima F Kaddurah-Daouk et al. · 2023 · Scientific Reports
  16. ABCA7-dependent induction of neuropeptide Y is required for synaptic resilience in Alzheimer’s disease through BDNF/NGFR signaling
    Hüseyin Tayran, E. Yılmaz, P. Bhattarai, Yu-Hao Min, Xue Wang, Yi-Yi Ma, Ni Wang, Inyoung Jeong, Nastasia Nelson, Nada Kassara et al. · 2024 · Cell Genomics
  17. Oxygen-induced stress reveals context-specific gene regulatory effects in human brain organoids
    Benjamin D. Umans, Yoav Gilad · 2025 · Genome Research
  18. CellBiAge: Improved single-cell age classification using data binarization
    Doudou Yu, Manlin Li, Guanjie Linghu, Yihuan Hu, Kaitlyn H. Hajdarovic, An Wang, Ritambhara Singh, Ashley E. Webb · 2023 · Cell Reports
  19. Pursuit of precision medicine: Systems biology approaches in Alzheimer's disease mouse models
    Brianna Gurdon, Catherine Cook Kaczorowski · 2021 · Neurobiology of Disease
  20. Mitochondrial unfolded protein response (UPR mt ) as novel therapeutic targets for neurological disorders
    Xi Chen, Hong An, Jiachen He, Jiaqi Guo, Shuaili Xu, Chuanjie Wu, Di Wu, Xunming Ji · 2025 · Journal of Cerebral Blood Flow & Metabolism
  21. Cross species systems biology discovers glial DDR2, STOM, and KANK2 as therapeutic targets in progressive supranuclear palsy
    Yuhao Min, Xue Wang, Özkan İş, Tulsi Patel, Junli Gao, Joseph S. Reddy, Zachary Quicksall, Thuy Nguyen, Shu Lin, Frederick Q Tutor‐New et al. · 2023 · Nature Communications
  22. Activation of the muscle-to-brain axis ameliorates neurocognitive deficits in an Alzheimer’s disease mouse model via enhancing neurotrophic and synaptic signaling
    Hash Brown Taha, Allison Birnbaum, Ian Matthews, Karel Aceituno, Jocelyne Leon, Max Andrew Thorwald, José A. Godoy-Lugo, Constanza J. Cortés · 2024 · GeroScience
  23. Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL-AD preclinical testing core study
    Onos, Kristen D., Quinney, Sara K., Jones, David R., Masters, Andrea R., Pandey, Ravi, Keezer, Kelly J., Biesdorf, Carla, Metzger, Ingrid F., Meyers, Jill A., Peters, Johnathon et al. · 2022 · Alzheimer's & Dementia: Translational Research & Clinical Interventions
  24. Molecular hallmarks of excitatory and inhibitory neuronal resilience to Alzheimer’s disease
    Isabel Castanho, Pourya Naderi Yeganeh, Carles A. Boix, Sarah L. Morgan, Hansruedi Mathys, Dmitry Prokopenko, Bartholomew White, Larisa M. Soto, Giulia Pegoraro, Saloni A. Shah et al. · 2025 · Molecular Neurodegeneration
  25. Nontransgenic Guinea Pig Strains Exhibit Hallmarks of Human Brain Aging and Alzheimer’s Disease
    Devin Wahl, Julie A. Moreno, Kelly S. Santangelo, Qian Yun Zhang, Maryam F. Afzali, Maureen Walsh, Robert V. Musci, Alyssa N. Cavalier, Karyn L. Hamilton, Thomas J. LaRocca · 2022 · The Journals of Gerontology Series A
  26. A Comprehensive and Integrative Approach to MeCP2 Disease Transcriptomics
    Alexander J. Trostle, Lucian Li, Seon‐Young Kim, Jiasheng Wang, Rami Al‐Ouran, Hari Krishna Yalamanchili, Zhandong Liu, Ying‐Wooi Wan · 2023 · International Journal of Molecular Sciences
  27. Tau polarizes an aging transcriptional signature to excitatory neurons and glia
    Timothy Wu, Jennifer Deger, Hui Ye, Caiwei Guo, Justin S. Dhindsa, Brandon T. Pekarek, Rami Al‐Ouran, Zhandong Liu, Ismael Al‐Ramahi, Juan Botas et al. · 2023 · eLife
  28. CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PET
    Kwangsik T. Nho, Shannon L. Risacher, Liana G. Apostolova, Paula J. Bice, Jared R. Brosch, Rachael L. Deardorff, Kelley M. Faber, Martin Rhys Farlow, Tatiana Foroud, Sujuan Gao et al. · 2024 · Nature Communications
  29. Recent Applications of Bioinformatics in Target Identification and Drug Discovery for Alzheimer’s Disease
    Sushil Kumar Singh, Ashok Kumar, Ravi Bhushan Singh, Powsali Ghosh, Nilesh Gajanan Bajad · 2022 · Current Topics in Medicinal Chemistry
  30. Conserved cell-type specific signature of resilience to Alzheimer’s disease nominates role for excitatory intratelencephalic cortical neurons
    Maria A. Telpoukhovskaia, Niran Hadad, Brianna Gurdon, Yanchao Dai, Andrew R. Ouellette, Sarah M. Neuner, Amy R. Dunn, Jon A. L. Willcox, Yiyang Wu, Logan C. Dumitrescu et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  31. Transcriptomics of the Prader–Willi syndrome hypothalamus
    Elena G. Bochukova · 2021 · Handbook of clinical neurology
  32. A TrkB and TrkC partial agonist restores deficits in synaptic function and promotes activity‐dependent synaptic and microglial transcriptomic changes in a late‐stage Alzheimer's mouse model
    Amira Latif‐Hernandez, Tao Yang, Robert R. Butler, Patricia Morán Losada, Paras Singh Minhas, Halle White, Kevin C Tran, Harry Liu, Danielle A. Simmons, Vanessa F. Langness et al. · 2024 · Alzheimer s & Dementia
  33. An Integrated Molecular Atlas of Alzheimer’s Disease
    Maria A. Wörheide, Jan Krumsiek, Serge Nataf, Kwangsik T. Nho, Anna K. Greenwood, Jesse C. Wiley, Lina-Liv Willruth, Tong Wu, Orhan Bellur, Bharadwaj Marella et al. · 2021 · medRxiv
  34. Multi-region brain transcriptomes uncover two subtypes of aging individuals with differences in Alzheimer risk and the impact of APOEε4
    Annie Lee, Yiyi Ma, Lei Yu, Robert J. Dawe, Cristin Aubin, Konstantinos Arfanakis, Richard P Mayeux, David Alan Bennett, Hans‐Ulrich Klein, Philip L. De Jager · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  35. Therapeutic Potential of Nanomedicine in Management of Alzheimer’s Disease and Glioma
    Firoz Anwar, Fahad Ahmed Al-Abbasi, Salma Naqvi, Ryan Adnan Sheikh, Sultan Alhayyani, Amer H. Asseri, Turky Omar Asar, Vikas Kumar · 2023 · International Journal of Nanomedicine
  36. Multi Layered Omics Approaches Reveal Glia Specific Alterations in Alzheimer's Disease: A Systematic Review and Future Prospects
    Özkan İş, Yuhao Min, Xue Wang, Stephanie R. Oatman, Ann Abraham Daniel, Nilüfer Ertekin‐Taner · 2024 · Glia
  37. Divergent TDP43-regulated and TDP43-independent cryptic splicing in the cortex and spinal cord
    Dwight F. Newton, Rena Yang, Johnny Gutierrez, Jeffrey W. Hofmann, Sreedevi Chalasani, Felix L. Yeh, Anne Biever, Brad A. Friedman · 2026 · Molecular Neurodegeneration Advances
  38. Pooled analysis of frontal lobe transcriptomic data identifies key mitophagy gene changes in Alzheimer's disease brain
    Taoyu Mei, Yuan Li, Anna Orduña Dolado, Zhiquan Li, Robin Andersson, L. Berliocchi, L. Rasmussen · 2023 · Frontiers in Aging Neuroscience
  39. Transcriptional risk scores in Alzheimer's disease: From pathology to cognition
    Jung‐Min Pyun, Young Ho Park, Jiebiao Wang · 2023 · Alzheimer s & Dementia
  40. In vivo validation of late‐onset Alzheimer's disease genetic risk factors
    Michael Sasner, Christoph Preuß, Ravi S. Pandey, Asli Uyar, Dylan T. Garceau, Kevin P. Kotredes, Harriet M. Williams, Adrian L. Oblak, Peter Bor‐Chian Lin, Bridget M Perkins et al. · 2024 · Alzheimer s & Dementia
  41. Transcriptomic signatures of oxytosis/ferroptosis are enriched in Alzheimer’s disease
    Antonio Jose Martins Currais, Kayla L. Sanchez, David Soriano‐Castell, Nawab John Dar, K. Garrett Evensen, Salvador Soriano, Pamela A Maher · 2025 · BMC Biology
  42. mosGraphGPT: a foundation model for multi-omic signaling graphs using generative AI
    Heming Zhang, Di Huang, Emily Chen, Dekang Cao, Tianma Xu, Ben Dizdar, Guangfu Li, Yixin Chen, Philip Payne, Michael A. Province et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  43. Large-scale gene expression changes in APP/PSEN1 and GFAP mutation models exhibit high congruence with Alzheimer’s disease
    Stephen C. Gammie, Albee Messing, Mason A. Hill, Cynthia A. Kelm‐Nelson, Tracy L. Hagemann · 2024 · PLoS ONE
  44. Bioinformatics Analysis of Publicly Available Single-Nuclei Transcriptomics Alzheimer’s Disease Datasets Reveals APOE Genotype-Specific Changes Across Cell Types in Two Brain Regions
    Stella Belonwu, Yaqiao Li, Daniel G. Bunis, Arjun Arkal Rao, Caroline Warly Solsberg, Tomiko Oskotsky, Alice L. Taubes, Brian P. Grone, Kelly A. Zalocusky, Gabriela K. Fragiadakis et al. · 2022 · Frontiers in Aging Neuroscience
  45. Microglial Responses to Alzheimer's Disease Pathology: Insights From “Omics” Studies
    Aquene N. Reid, Suman Jayadev, Katherine E. Prater · 2025 · Glia
  46. Leveraging multiomic approaches to elucidate mechanisms of heterogeneity in Alzheimer's disease: Neuropsychiatric symptoms, co‐pathologies, and sex differences
    Elliot Keats Shwab, Gita A. Pathak, Joshua Harvey, Michaël E. Belloy, Corinne Eleanor Fischer, Michael William Lutz, Sonja W. Scholz, Noah Cook, Danielle Marie Reid, Jingchun Chen et al. · 2025 · Alzheimer s & Dementia
  47. Building in vitro models of the brain to understand the role ofAPOEin Alzheimer’s disease
    Rebecca L. Pinals, Li‐Huei Tsai · 2022 · Life Science Alliance
  48. Case-control virtual histology elucidates cell types associated with cortical thickness differences in Alzheimer's disease
    Isabel Kerrebijn, Michael Wainberg, Peter Zhukovsky, Yuxiao Chen, Melanie Davie, Daniel Felsky, Shreejoy J. Tripathy · 2023 · NeuroImage
  49. Sex- and region-specific cortical and hippocampal whole genome transcriptome profiles from control and APP/PS1 Alzheimer’s disease mice
    Anna Papazoglou, Christina Henseler, Sandra Weickhardt, Jenni Teipelke, Παναγιώτα Παπάζογλου, Johanna Daubner, Teresa Schiffer, Damian Krings, Karl Broich, Jürgen Hescheler et al. · 2024 · PLoS ONE
  50. Single-cell and nucleus RNA-seq in a mouse model of AD reveal activation of distinct glial subpopulations in the presence of plaques and tangles
    Gabriela Balderrama-Gutierrez, Heidi Yahan Liang, Narges Rezaie, Klébea Carvalho, Stefânia Forner, Dina P. Matheos, Elisabeth Rebboah, Kim N. Green, Andrea J. Tenner, Frank M. LaFerla et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  51. Transcriptomic imputation of genetic risk variants uncovers novel whole-blood biomarkers of Parkinson’s disease
    Gabriel Chew, Aaron Shengting Mai, John F. Ouyang, Yueyue Qi, Yinxia Chao, Qing Wang, Enrico G. Petretto, Eng‐King Tan · 2024 · npj Parkinson s Disease
  52. Looking at Alzheimer’s Disease Pathogenesis from the Nuclear Side
    Laura D’Andrea, Ramona Stringhi, Mónica Di Luca, Elena E. Marcello · 2021 · Biomolecules
  53. Protect Effects of Seafood-Derived Plasmalogens Against Amyloid-Beta (1–42) Induced Toxicity via Modulating the Transcripts Related to Endocytosis, Autophagy, Apoptosis, Neurotransmitter Release and Synaptic Transmission in SH-SY5Y Cells
    Junli Feng, Gongshuai Song, Qing Shen, Xi Chen, Qingcheng Wang, Shunyuan Guo, Manman Zhang · 2021 · Frontiers in Aging Neuroscience
  54. Systems biology approaches to unravel the molecular and genetic architecture of Alzheimer's disease and related tauopathies
    Miyoshi, Emily, Morabito, Samuel, Swarup, Vivek · 2021 · Neurobiology of Disease
  55. Meta-analysis of Transcriptomic Data from Lung Autopsy and Cellular Models of SARS-CoV-2 Infection
    Nathan Araujo Cadore, Vinícius Oliveira Lord, Mariana Recamonde‐Mendoza, Thayne Woycinck Kowalski, Fernanda Sales Luiz Vianna · 2023 · Biochemical Genetics
  56. A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer’s Disease via ITGA5
    Ali Mahzarnia, Michael William Lutz, Alexandra Badea · 2023 · Journal of Alzheimer s Disease
  57. Identification of gene networks mediating regional resistance to tauopathy in late-onset Alzheimer’s disease
    Christopher A. Ayoub, Connor S. Wagner, Jeff Kuret · 2023 · PLoS Genetics
  58. The fusiform gyrus exhibits differential gene-gene co-expression in Alzheimer's disease
    Arthur Ribeiro-dos-Santos, Leonardo Miranda Brito, Gilderlânio Santana de Araújo · 2023 · Frontiers in Aging Neuroscience
  59. Weakly activated core inflammation pathways were identified as a central signaling mechanism contributing to the chronic neurodegeneration in Alzheimer’s disease
    Fuhai Li, Abdallah M. Eteleeb, William Buchser, Guoqiao Wang, Chengjie Xiong, Philip Payne, Eric McDade, Celeste M M. Karch, Oscar Harari, Carlos Cruchaga · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  60. Path-based reasoning for biomedical knowledge graphs with BioPathNet
    Yue Hu, Svitlana Oleshko, Samuele Firmani, Zhaocheng Zhu, Hui Cheng, Maria A. Wörheide, Matthias Arnold, Maria Colomé‐Tatché, Jian Tang, Sophie Xhonneux et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  61. Towards Better and More Valid Zebrafish Models of Alzheimer's Disease: A Scientific Tribute to Prof. Mikhail I. Aghajanov
    Maria M. Kotova, Adam Stewart, Artem Grigoryan, Sanobar Shariff, Foad Mirzaei, Burhan Kantawala, Karen Dilbaryan, Murilo S. de Abreu, David S. Galstryan, Jiahao Cui et al. · 2025 · Journal of Neurochemistry
  62. In silico identification of novel stilbenes analogs for potential multi-targeted drugs against Alzheimer’s disease
    Sundas Firdoos, Rongji Dai, Rana Adnan Tahir, Zahid Younas Khan, Hui Li, Jun Zhang, Junjun Ni, Zhenzhen Quan, Hong Qing · 2023 · Journal of Molecular Modeling
  63. Gene co-expression changes underlying the functional connectomic alterations in Alzheimer’s disease
    Bing He, Priyanka Gorijala, Linhui Xie, Sha Cao, Jingwen Yan · 2022 · BMC Medical Genomics
  64. Analysis of modular gene co-expression networks reveals molecular pathways underlying Alzheimer’s disease and progressive supranuclear palsy
    Lukas da Cruz Carvalho Iohan, Jean‐Charles Lambert, Marcos R. Costa · 2022 · PLoS ONE
  65. Prospective Evaluation of an Amide-Based Zinc Scaffold as an Anti-Alzheimer Agent: In Vitro, In Vivo, and Computational Studies
    Wajeeha Waseem, Fareeha Anwar, Uzma Saleem, Bashir Ahmad, Rehman Zafar, Asifa Anwar, Muhammad Saeed Jan, Umer Rashid, Abdul Sadiq, Tariq Ismail · 2022 · ACS Omega
  66. Alzheimer’s disease protein relevance analysis using human and mouse model proteomics data
    Cathy Shi, William Kirby Gottschalk, Carol A. Colton, Sayan Mukherjee, Michael William Lutz · 2023 · Frontiers in Systems Biology
  67. Estimating Cell-Type-Specific Gene Co-Expression Networks from Bulk Gene Expression Data with an Application to Alzheimer’s Disease
    Chang Su, Jingfei Zhang, Hongyu Zhao · 2023 · Journal of the American Statistical Association
  68. HILIC-UHPLC-QTRAP®/MS2 quantification of 15 neurotransmitters of the combination of donepezil and ginkgo ketoester tablet in different biological matrices from dementia mice: Application to study the synergistic effect of the two drugs
    Guisheng Zhou, Jing Zhang, You Yin, Ya‐Jie Tan, Hui‐Juan Tao, Jiaqian Chen, Zong‐Jin Pu, Zhenhua Zhu, Xu-Qin Shi, Yuping Tang et al. · 2020 · Microchemical Journal
  69. Modulating innate immune activation states impacts the efficacy of specific Aβ immunotherapy
    Yona Levites, Cory C. Funk, Xue Wang, Paramita Chakrabarty, Karen N. McFarland, Baxter Bramblett, Veronica O’Neal, Xufei Liu, Thomas B. Ladd, Max Robinson et al. · 2021 · Molecular Neurodegeneration
  70. Depression-related phenotypes at early stages of Aβ and tau accumulation in inducible Alzheimer's disease mouse model: Task-oriented and concept-driven interpretations
    Erica C. Leyder, Prakul Suresh, Rachel A. Jun, Katherine Overbey, Tirtho Banerjee, Tatiana Melnikova, Alena V. Savonenko · 2022 · Behavioural Brain Research
  71. Genome-wide consensus transcriptional signatures identify synaptic pruning linking Alzheimer’s disease and epilepsy
    Huihong Li, Zhiran Xie, Yuxuan Tian, Ruoyin Zhou, Yaxi Yang, Bingying Lin, Si Chen, Jie Wu, Zihan Deng, Jianwei Li et al. · 2025 · Molecular Psychiatry
  72. Integrated Multi‐Omics Analysis and Cross‐Model Validation Reveal Mitochondrial Signatures in Alzheimer's Disease
    Xuan Xu, Shasha Fan, Li Jiang, Hao Wu, Junwen He, Yang He, Xiangyu Meng, Yin Shen · 2025 · CNS Neuroscience & Therapeutics
  73. Oral administration of liposome-encapsulated thymol could alleviate the inflammatory parameters in serum and hippocampus in a rat model of Alzheimer's disease
    Asal Safarbalou, Adeel Ahmed Abbasi · 2024 · Experimental Gerontology
  74. Planar π‒π stacking interactions stabilized 3D structure of a dimeric Zn(II) complex: Crystal structure, DFT calculations, and anti-Alzheimer and anti-Parkinson potentials
    Swah Mohd. Nashre‐ul‐Islam, Kamala Kanta Borah, Füreya Elif Öztürkkan · 2024 · Journal of Molecular Structure
  75. Spatial coding dysfunction and network instability in the aging medial entorhinal cortex
    Charlotte S. Herber, Karishma J. B. Pratt, Jeremy M. Shea, Saul Villeda, Lisa Marie Giocomo · 2025 · Nature Communications
  76. Transcriptome and Translatome Regulation of Pathogenesis in Alzheimer’s Disease Model Mice
    Guillermo Eastman, Elizabeth R. Sharlow, John S. Lazo, George S. Bloom, José Roberto Sotelo-Silveira · 2022 · Journal of Alzheimer s Disease
  77. In-silico studies of Neurocognitive and Neuropharmacological effect of Bacopa monnieri (L.)
    Satyam Sangeet, Arshad Ali Khan · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  78. Mouse-to-human modeling of microglia single-nuclei transcriptomics identifies immune signaling pathways and potential therapeutic candidates associated with Alzheimer’s disease
    Alexander M. Bergendorf, Jee Hyun Park, Brendan K. Ball, Douglas K. Brubaker · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  79. Extracellular RNAs as Messengers and Early Biomarkers in Neurodegeneration
    Ke Lü, Magdalena J. Koziol · 2025 · International Journal of Molecular Sciences
  80. Single‐cell landscape of sex‐specific drivers of Alzheimer's disease
    Yiyang Wu, Kyle J. Travaglini, Mariano I. Gabitto, Christopher Dirk Keene, Amy R. Dunn, Catherine Cook Kaczorowski, Philip L. De Jager, Vilas Menon, Julie A. Schneider, David A. A Bennett et al. · 2025 · Alzheimer s & Dementia
  81. Integrative epigenomic landscape of Alzheimer’s Disease brains reveals oligodendrocyte molecular perturbations associated with tau
    Oatman, Stephanie R., Reddy, Joseph S., Atashgaran, Amin, Wang, Xue, Min, Yuhao, Quicksall, Zachary, Vanelderen, Floor, Carrasquillo, Minerva M., Liu, Chia-Chen, Yamazaki, Yu et al. · 2026 · Nature Communications
  82. Amyloid-Beta Peptides Trigger Premature Functional and Gene Expression Alterations in Human-Induced Neurons
    Ana Raquel Melo de Farias, Alexandre Pelletier, Lukas da Cruz Carvalho Iohan, Orthis Saha, Amélie Bonnefond, Philippe Amouyel, Fabien Delahaye, Jean‐Charles Lambert, Marcos R. Costa · 2023 · Biomedicines
  83. RNA Modifications in Neurodegenerations
    Eleonora Calzoni, Chiara Argentati, Alessio Cesaretti, Nicolò Montegiove, Ilaria Tortorella, Martina Bazzucchi, Francesco Morena, Sabata Martino, Carla Emiliani · 2021 · RNA technologies
  84. Hippocampus Glutathione S Reductase Potentially Confers Genetic Resilience to Cognitive Decline in the AD-BXD Mouse Population
    Michael C. Saul, ELIZABETH M. LITKOWSKI, Niran Hadad, Amy R. Dunn, Stephanie M. Boas, Jon A. L. Willcox, Julia E. Robbins, Yiyang Wu, Vivek M. Philip, Gennifer E. Merrihew et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  85. Molecular hallmarks of excitatory and inhibitory neuronal resilience and resistance to Alzheimer’s disease
    Isabel Castanho, Pourya Naderi Yeganeh, Carles A. Boix, Sarah L. Morgan, Hansruedi Mathys, Dmitry Prokopenko, Bartholomew White, Larisa M. Soto, Giulia Pegoraro, Saloni A. Shah et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  86. Meta‐Analysis of Transcriptomic Studies of Blood and Six Brain Regions Identifies a Consensus of 15 Cross‐Tissue Mechanisms in Alzheimer's Disease and Suggests an Origin of Cross‐Study Heterogeneity
    Jiahui Hou, Jonathan Hess, Chunling Zhang, Jeroen van Rooij, Gentry C. Hearn, Chun Chieh Fan, Stephen V. Faraone, Christine Fennema‐Notestine, Shu‐Ju Lin, Valentina Escott‐Price et al. · 2024 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  87. Short-lived Niemann-Pick type C mice with accelerated brain aging as a novel model for Alzheimer’s disease research
    Vikas Anil Gujjala, Morteza Abyadeh, Isaiah Klimek, Alexander Tyshkovskiy, Naci Oz, José Pedro Castro, Vadim N. Gladyshev, Jason C. Newton, Alaattin Kaya · 2025 · Neural Regeneration Research
  88. Improving mouse models for the study of Alzheimer's disease
    Alaina M. Reagan, Kristen D. Onos, Sarah E. Heuer, Michael Sasner, Gareth R. Howell · 2022 · Current topics in developmental biology/Current Topics in Developmental Biology
  89. Levetiracetam modulates brain metabolic networks and transcriptomic signatures in the 5XFAD mouse model of Alzheimer’s disease
    Charles P. Burton, Evgeny J. Chumin, Alyssa Y. Collins, Scott A. Persohn, Kristen D. Onos, Ravi S. Pandey, Sara K. Quinney, Paul R. Territo · 2024 · Frontiers in Neuroscience
  90. A role for the autophagy receptor NBR1 in the degradation of tau aggregates
    Marie Neu, Iwan Parfentev, Gregory K. Potts, Nina Stöberl, Jürgen Korffmann, Andreas Striebinger, Daniela Geist, Dimitris N. Papageorgiou, Hanna Tarhonskaya, Nicholas McKitterick et al. · 2025 · Neurobiology of Disease
  91. Quality of life among post-stroke Jordanian survivors: a prospective study
    Marwa Nayef Alhalabi, Salam Bani Hani · 2022 · Working with Older People
  92. Leveraging selective hippocampal vulnerability among Alzheimer’s disease subtypes reveals a novel tau binding partner SERPINA5
    Angela M. Crist, Kelly M. Hinkle, Xue Wang, Christina M. Moloney, Billie J. Matchett, Sydney A. Labuzan, Isabelle Frankenhauser, Nkem O. Azu, Amanda M. Liesinger, Elizabeth R. Lesser et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  93. Small molecules from Bacopa monneiri as potent inhibitors against Neurodegenerative Disorders
    Satyam Sangeet, Arshad Khan · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  94. Silencing of ApoE with Divalent siRNAs Drives Activation of Immune Clearance Pathways and Improves Amyloid Pathology in Mouse Models of Alzheimer’s Disease
    Chantal M. Ferguson, Samuel R. Hildebrand, Bruno M.D.C. Godinho, Julianna E. Buchwald, Dimas Echeverria, Andrew H. Coles, Anastasia P. Grigorenko, Lorenc Vanjielli, Jacquelyn Sousa, Nicholas McHugh et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  95. The YTHDF proteins shape the brain gene signatures of Alzheimer’s disease
    Shinya Tasaki, Denis R. Avey, Nicola A. Kearns, Chunjiang Yu, Sashini L De Tissera, Himanshu Vyas, Lin Cheng, Jishu Xu, Artemis Iatrou, Daniel J. Flood et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  96. Therapeutic Potential of Irisin in Neurodegenerative Diseases
    Sania Muzaffar, Alpna Tyagi, Subbiah Pugazhenthi · 2025 · International Journal of Molecular Sciences
  97. The tyrosine kinase inhibitor LPM4870108 impairs learning and memory and induces transcriptomic and gene‑specific DNA methylation changes in rats
    Sijin Duan, Chunmei Li, Yonglin Gao · 2022 · Archives of Toxicology
  98. An Overview of the Natural Neuroprotective Agents for the Management of Cognitive Impairment Induced by Scopolamine in Zebrafish (Danio rerio)
    Sara Abidar, Lucian Hriţcu, Mohamed Nhiri · 2024 · CNS & Neurological Disorders - Drug Targets
  99. Prioritizing disease-related rare variants by integrating gene expression data
    Hanmin Guo, Alexander Eckehart Urban, Wing Hung Wong · 2024 · PLoS Genetics
  100. Genome‐wide transcriptome analysis of Aβ deposition on PET in a Korean cohort
    Tamina Park, Jiyun Hwang, Shiwei Liu, Soumilee Chaudhuri, Sang Won Han, Dahyun Yi, Min Soo Byun, Yen-Ning Huang, Thea Jacobson Rosewood, Gijung Jung et al. · 2024 · Alzheimer s & Dementia